Krystal Biotech, Inc.
NASDAQ:KRYS
182.74 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 358.328 | 161.9 | 341.246 | 268.269 | 187.514 | 103.67 | 49.591 | 1.923 |
| Short Term Investments
| 173.85 | 217.271 | 96.85 | 2.993 | 6.171 | 8.091 | 0 | 0 |
| Cash and Short Term Investments
| 532.178 | 379.171 | 438.096 | 271.262 | 193.685 | 111.761 | 49.591 | 1.923 |
| Net Receivables
| 42.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 6.985 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 6.706 | 4.608 | 4.171 | 3.796 | 2.195 | 0.889 | 0.019 | 0.246 |
| Total Current Assets
| 587.909 | 383.779 | 442.267 | 275.058 | 195.88 | 112.65 | 49.914 | 2.169 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 168.229 | 169.726 | 119.583 | 34.174 | 11.184 | 3.014 | 0.2 | 0.013 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 61.954 | 4.621 | 64.371 | 0 | 0.497 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.263 | 0.324 | 0.074 | 1.612 | 1.462 | 0.452 | 0 | 0 |
| Total Non-Current Assets
| 230.446 | 174.671 | 184.028 | 35.786 | 13.143 | 3.466 | 0.2 | 0.013 |
| Total Assets
| 818.355 | 558.45 | 626.295 | 310.844 | 209.023 | 116.116 | 50.114 | 2.182 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 4.132 | 3.981 | 8.398 | 2.105 | 0.724 | 0.888 | 0.193 | 0.042 |
| Short Term Debt
| 1.474 | 1.561 | 1.041 | 8.238 | 0.48 | 0 | 0 | 0 |
| Tax Payables
| 2.283 | 0.043 | 0.083 | 0.04 | 0.04 | 0.154 | 0.103 | 0 |
| Deferred Revenue
| 0 | 0 | 16.21 | 5.083 | 2.104 | 0 | 0 | 0 |
| Other Current Liabilities
| 27.488 | 23.305 | 0.087 | 0.026 | 0.019 | 1.708 | 0.447 | 0.001 |
| Total Current Liabilities
| 33.094 | 28.847 | 25.736 | 15.452 | 3.327 | 2.596 | 0.64 | 0.043 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 6.62 | 7.372 | 6.983 | 3.308 | 2.782 | 0 | 0 | 1.843 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| -0 | 0 | 0 | 0 | 0 | 0.294 | 0 | 0.007 |
| Total Non-Current Liabilities
| 6.62 | 7.372 | 6.983 | 3.308 | 2.782 | 0.294 | 0 | 1.85 |
| Total Liabilities
| 39.714 | 36.219 | 32.719 | 18.76 | 6.109 | 2.89 | 0.64 | 1.893 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 116.116 | 50.114 | 1.406 |
| Common Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -269.827 | -280.759 | -140.784 | -71.214 | -39.047 | -19.959 | -9.07 | -1.15 |
| Accumulated Other Comprehensive Income/Loss
| 0.638 | -0.728 | -0.163 | 0.006 | 0.01 | 0.002 | -0.025 | -0.002 |
| Other Total Stockholders Equity
| 1,047.83 | 803.718 | 734.523 | 363.292 | 241.951 | 17.067 | 8.455 | 0.035 |
| Total Shareholders Equity
| 778.641 | 522.231 | 593.576 | 292.084 | 202.914 | 113.226 | 49.474 | 0.289 |
| Total Equity
| 778.641 | 522.231 | 593.576 | 292.084 | 202.914 | 113.226 | 49.474 | 0.289 |
| Total Liabilities & Shareholders Equity
| 818.355 | 558.45 | 626.295 | 310.844 | 209.023 | 116.116 | 50.114 | 2.182 |